Illumina, Inc. (ILMN)

319.09
0.06 0.02
NASDAQ
Prev Close 319.03
Open 318.58
Day Low/High 315.75 / 321.42
52 Wk Low/High 221.49 / 372.61
Volume 524.87K
Exchange NASDAQ
Shares Outstanding 146.91B
Market Cap 46.87B
Div & Yield N.A. (N.A)
Why Surging eBay Could Rip Even Higher

Why Surging eBay Could Rip Even Higher

Here come the gains.

Illumina Tops the Nasdaq 100 -- and Here's How to Trade It

Illumina Tops the Nasdaq 100 -- and Here's How to Trade It

Shares of biotech company Illumina are leading the Nasdaq higher with a surge of more than 4.5% on Friday.

GRAIL Plans To Raise In Excess Of $1B In Series B Funding

GRAIL Plans To Raise In Excess Of $1B In Series B Funding

Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors.

Garret Hampton (Photo: Business Wire)

Garret Hampton (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN), continuing its strategy to bring the power of genomics into clinical applications, today announced it has named one of the world's top clinical genomics experts to head its clinical genomics...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Illumina, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Illumina, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf...

ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina, Inc. Investors Of Important Deadline In Class Action - ILMN

ILMN LOSS NOTICE: Rosen Law Firm Reminds Illumina, Inc. Investors Of Important Deadline In Class Action - ILMN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc.

Illumina To Webcast Live Presentation At The J.P. Morgan Annual Healthcare Conference  

Illumina To Webcast Live Presentation At The J.P. Morgan Annual Healthcare Conference  

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the J.

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Illumina, Inc. Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Illumina, Inc. Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Illumina, Inc.

Jonathan Seaton (Photo: Business Wire)

Jonathan Seaton (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company continues...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Illumina, Inc. - ILMN

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Illumina, Inc. - ILMN

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Illumina, Inc.

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Illumina, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Illumina, Inc. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Illumina, Inc.

Illumina: The Bears Have Taken Control

Illumina: The Bears Have Taken Control

Considering the major top formation, don't get in their way.

Bearish Bets: A Gold Producer, a Drug Giant and Other Stocks That Look Good Short

HIMX, GG, ABT, ILMN and ENT all were recently downgraded by TheStreet's Quant Ratings.

Sam Samad (Photo: Business Wire)

Sam Samad (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Sam A.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADTN, DOOR, FFKT, FORM, NSH, OBCI, PKX, RGS, SCAI, SPLS, TOL, ZEUS Downgrades: CCE, DTEA, ENT, EVH, ILMN Initiations: FORK Read on to get TheStreet Quant Ratings' detailed report:

Illumina Launches IHope Program To Identify Causes Of Undiagnosed Genetic Diseases In Children

Illumina Launches IHope Program To Identify Causes Of Undiagnosed Genetic Diseases In Children

Illumina, Inc. (NASDAQ: ILMN) today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed rare diseases in children.

Illumina To Webcast Live Presentation At The Citi Global Healthcare Conference

Illumina To Webcast Live Presentation At The Citi Global Healthcare Conference

Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Citi Global Healthcare Conference in New York, NY, on December 7, 2016.

Illumina Becomes #232 Most Shorted S&P 500 Component, Replacing Xylem

Illumina Becomes #232 Most Shorted S&P 500 Component, Replacing Xylem

The most recent short interest data has been released for the 10/31/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina And Mayo Clinic Form Bioinformatics Relationship To Advance Genetic Disorder Testing

Illumina And Mayo Clinic Form Bioinformatics Relationship To Advance Genetic Disorder Testing

Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo's delivery of genetic and genomic...

Illumina Launches TruSight Tumor 170

Illumina Launches TruSight Tumor 170

Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm from a series of...

Illumina Reports Full Financial Results For Third Quarter Of Fiscal Year 2016

Illumina Reports Full Financial Results For Third Quarter Of Fiscal Year 2016

Illumina, Inc. (NASDAQ:ILMN) today announced its full financial results for the third quarter of fiscal year 2016.

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

Week Ahead: Fed Meeting, Jobs Report Paint Clearer Picture for Rate Hike Chances

The Federal Reserve will again convene in the coming week to discuss monetary policy, but investors will instead focus on what it may mean for a rate hike in December.

Should You Sell Illumina Stock?

Should You Sell Illumina Stock?

Gene sequencer Illumina has shaken investors' faith with negative announcements this year.

German Court Issues Preliminary Injunction Against Amedes Fetalis® Test For Infringement Of Non-Invasive Prenatal Screening Patent

German Court Issues Preliminary Injunction Against Amedes Fetalis® Test For Infringement Of Non-Invasive Prenatal Screening Patent

Illumina, Inc. (NASDAQ: ILMN) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, today announced that on October 5, 2016, the Düsseldorf...

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Illumina Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Illumina Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Illumina Inc.

INVESTOR ALERT: Investigation Of Illumina Inc. Announced By Law Offices Of Howard G. Smith

INVESTOR ALERT: Investigation Of Illumina Inc. Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Illumina Inc.

Illumina Contributes To ClinVar Database

Illumina Contributes To ClinVar Database

Illumina, Inc. (NASDAQ: ILMN) announced today that it has contributed over 95,000 human genetic variants to ClinVar, a public database hosted by the National Center for Biotechnology Information (NCBI).

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

What IBM's Genomic Partnership With Quest Says About Thermo Fisher, Diagnostics Peers

Quest and IBM are rolling out a genomic sequencing service powered by Big Blue's Watson supercomputer.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.

TheStreet Quant Rating: B (Buy)